Literature DB >> 1689901

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications.

J J Fung1, S Todo, A Jain, J McCauley, M Alessiani, C Scotti, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1689901      PMCID： PMC2903869     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  18 in total

1.  Studies of the induction and maintenance of long-term graft acceptance by treatment with FK506 in heterotopic cardiac allotransplantation in rats.

Authors:  T Ochiai; K Nakajima; M Nagata; S Hori; T Asano; K Isono
Journal:  Transplantation       Date:  1987-12       Impact factor: 4.939

2.  Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine.

Authors:  N Murase; S Todo; P H Lee; H S Lai; F Chapman; M A Nalesnik; L Makowka; T E Starzl
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

3.  FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.

Authors:  T Kino; H Hatanaka; S Miyata; N Inamura; M Nishiyama; T Yajima; T Goto; M Okuhara; M Kohsaka; H Aoki
Journal:  J Antibiot (Tokyo)       Date:  1987-09       Impact factor: 2.649

4.  Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids.

Authors:  S Todo; A J Demetris; Y Ueda; O Imventarza; K Okuda; A Casavilla; S Cemaj; A Ghalab; V Mazzaferro; B S Rhoe
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

5.  Renal transplantation in baboons under FK 506.

Authors:  S Todo; A Demetris; Y Ueda; O Imventarza; E Cadoff; A Zeevi; T E Starzl
Journal:  Surgery       Date:  1989-08       Impact factor: 3.982

6.  The effect of FK-506 on hyperacute rejection in presensitized rats.

Authors:  L Makowka; F Chapman; S Qian; A Zerbe; P H Lee; N Murase; R Saunders; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

7.  Observations about FK-506 in primates.

Authors:  R Calne; D S Collier; S Thiru
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

8.  Kidney transplantation in the dog receiving FK-506.

Authors:  D S Collier; S Thiru; R Calne
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

9.  Synthesis and structure-activity relationships of C-4-amino acid substituted monobactam analogs.

Authors:  K S Kim; J H Chambers
Journal:  J Antibiot (Tokyo)       Date:  1987-01       Impact factor: 2.649

10.  Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction.

Authors:  S Todo; Y Ueda; J A Demetris; O Imventarza; M Nalesnik; R Venkataramanan; L Makowka; T E Starzl
Journal:  Surgery       Date:  1988-08       Impact factor: 3.982
View more
  49 in total

1.  History of clinical transplantation.

Authors:  T E Starzl
Journal:  World J Surg       Date:  2000-07       Impact factor: 3.352

2.  Effect of renal ischemia on plasma levels of FK 506 in rats.

Authors:  M Sakr; G Zetti; J Gavaler; H Farghali; R Venkataramanan; G Carrieri; T Starzl; D Van Thiel
Journal:  Transplant Proc       Date:  1992-02       Impact factor: 1.066

3.  The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation.

Authors:  J J Fung; M Eliasziw; S Todo; A Jain; A J Demetris; J P McMichael; T E Starzl; P Meier; A Donner
Journal:  J Am Coll Surg       Date:  1996-08       Impact factor: 6.113

4.  Liver transplantation of American veterans under FK 506 immunosuppression: a preliminary report.

Authors:  L A Mieles; J J Fung; I Yokoyama; J McCauley; N Singh; S Todo; R D Gordon; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

5.  Changes in renal function after liver transplantation under FK 506.

Authors:  J McCauley; J J Fung; S Todo; A Jain; P Deballi; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

6.  A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine.

Authors:  J Fung; K Abu-Elmagd; A Jain; R Gordon; A Tzakis; S Todo; S Takaya; M Alessiani; A Demetris; O Bronster
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

7.  FK 506 in the management of transplant-related nephrotic syndrome and steroid-resistant nephrotic syndrome.

Authors:  J McCauley; R Shapiro; V Scantlebury; N Gilboa; M Jordan; C Jensen; A Naik; A Tzakis; D Ellis; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

8.  FK 506 conversion of renal allografts failing cyclosporine immunosuppression.

Authors:  M L Jordan; R Shapiro; C W Jensen; V Scantlebury; J Fung; A Tzakis; J McCauley; A Jain; J Demetrius; P Randhawa
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

Review 9.  Adverse effects associated with the use of FK 506.

Authors:  J J Fung; M Alessiani; K Abu-Elmagd; S Todo; R Shapiro; A Tzakis; D Van Thiel; J Armitage; A Jain; J McCauley
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

Review 10.  A risk-benefit assessment of tacrolimus in transplantation.

Authors:  M Winkler; U Christians
Journal:  Drug Saf       Date:  1995-05       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.